Hesperidin for Alzheimer's Disease

Also known as: Citrus bioflavonoid, Vitamin P

Hesperidin crosses the BBB and provides neuroprotection through anti-inflammatory and antioxidant mechanisms.

Mechanism of Action

Hesperidin inhibits acetylcholinesterase (similar to donepezil mechanism), activates TrkB/BDNF signaling, reduces amyloid-beta aggregation, and suppresses NF-κB-driven neuroinflammation. It also improves cerebral blood flow.

General mechanism: Citrus flavanone glycoside. AChE inhibitor, BDNF/TrkB activator, NF-κB inhibitor, Nrf2 activator. Crosses BBB.

Current Evidence

Preclinical AD models show improved cognition and reduced pathology. Epidemiological data links citrus flavonoid intake to reduced dementia risk. Clinical trials for cognitive health ongoing.

Clinical Status: Preclinical for AD. Phase I/II for cognitive health.

Safety Profile

Very safe. Naturally present in citrus fruits. Well-tolerated. No significant drug interactions at supplement doses.

Key Research Questions

View glossary entry →

← Back to Alzheimer's Disease Research